Molecular Docking Simulation

Molecular docking simulation predicts ligand-protein binding modes through computational protein-ligand interaction modelling. Virtual screening identifies drug candidates. Binding pose prediction informs structure-activity relationships. Free energy calculations estimate binding affinity. Ensemble docking accounts for protein flexibility.

Structure-based drug design employs docking predictions. Lead optimisation guided by docking improves binding. Regulatory submissions justify molecular modelling rationale. Clinical validation confirms docking predictions. Emerging quantum mechanics improve accuracy.